Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

HIV prevention at a crossroads: the promise of an HIV vaccine

This advocacy brief from IAVI and the IAS outline what we can gain through sustained investments in HIV vaccine research. From advancing the clinical pipeline, to conducting faster, smarter, and inclusive research, and strengthening regional vaccine research and manufacturing ecosystems, investments in HIV vaccine R&D represent a strategic opportunity to advance the HIV prevention field and broader vaccine development ecosystems.

Read more

Scientific Publications

Endocervix exhibits greater susceptibility to HIV-1 infection compared to ectocervix following ex vivo exposure to Transmitted/Founder HIV-1 variants

Read more

Scientific Publications

mRNA delivery of circumsporozoite protein epitope-based malaria vaccines induces protection in a mouse model

Read more

Scientific Publications

Highly functional and prolonged germinal center T follicular helper cell responses are associated with enhanced neutralizing antibody development

Read more

Scientific Publications

Vaccine confidence and potential implications for new tuberculosis vaccines

Read more

Scientific Publications

Safety and Immunogenicity of an rVSV Lassa Fever Vaccine Candidate

Read more

Press Releases

Encouraging results from a first-in-human Phase 1 clinical trial of IAVI’s Lassa vaccine candidate published in New England Journal of Medicine

November 6, 2025

One dose elicits robust and long-lasting immune responses in healthy adults in the U.S. and Liberia

Read more

Features

IAVI calls for innovative partnerships to sustain vaccine development at the World Vaccine Congress Europe 2025

October 30, 2025

IAVI’s experts underscored the value of equitable, regional partnerships in bringing new vaccines to market at this year’s convening in Amsterdam

Read more